X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

SEC Amends Rules on Required Financial Disclosures About Acquisitions and Dispositions

On May 20, 2020, the Securities and Exchange Commission (SEC) amended its rules governing financial ...

Read More >

CDC Issues Guidance On The Coronavirus For Employers

As the new coronavirus (COVID-19) slowly appears outside China, employers should take precautions to...

Read More >

Eight Data Security Best Practices Revealed by Recent AG and FTC Enforcement Actions

Although there is no standard set of measures that a company can implement to guarantee that it will...

Read More >

Blog: SEC adopts final amendments for M&A financial statement disclosure

Yesterday, once again without an open meeting, the SEC voted (with a dissent from Commissioner Allis...

Read More >

A Force Majeure Trap Within Construction Contracts

Many people in the construction industry believe the force majeure clause waives the requirement for...

Read More >

Guidance For Employers To Protect Against Coronavirus (COVID-19)

With all of the recent news about the coronavirus outbreak in China, employers have increasingly bee...

Read More >